The Effect of Pre-exercise Feeding on Bone Turnover Biomarkers

NCT06550466 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2024-08-13

No results posted yet for this study

Summary

Osteoporosis is a major contributor to loss of independence due to bone fractures and resulting hospital treatments lead to significant morbidity. While pharmacological treatments can reduce consequences of osteoporosis, there is a pressing need for non-pharmacological interventions to improve bone health across the life-course and to reduce likelihood of age-related bone disease.

This study will allow us to determine whether synergistic potentiating effects on bone metabolism are observed in humans in relation to the timing of food ingestion and what recommendations can be made to people with respect to food ingestion and exercise to obtain the maximal bone benefits from aerobic exercise. Furthermore, if we can identify interventions that potentiate bone's response to aerobic exercise in younger adults, then such interventions may have the ability to maximise bone mass in younger adults so that with ageing, the additional bone mineral density and improved bone microarchitecture would extend the time before osteoporotic "fracture thresholds" are reached. Therefore, understanding the bone metabolic response to exercise following fasting and feeding in younger adults is important.

Conditions

  • Osteopenia or Osteoporosis

Interventions

OTHER

Breakfast only

Participants will attend a breakfast-only arm without the exercise protocol.

OTHER

FAST

Participants will be exercised for 90 minutes following a 12-hour overnight fast

OTHER

FED

Participants will be exercised 90 minutes after a breakfast

Sponsors & Collaborators

  • Anglia Ruskin University

    collaborator OTHER
  • University of Sheffield

    collaborator OTHER
  • Manchester Metropolitan University

    collaborator OTHER
  • Sheffield Teaching Hospitals NHS Foundation Trust

    collaborator OTHER
  • Sheffield Hallam University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
24 Years
Max Age
32 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-10-31
Primary Completion
2025-03-31
Completion
2025-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06550466 on ClinicalTrials.gov